Follow on Google News News By Tag * Cancer Diagnostics Market * Tumor Markers * Cancer Testing Market * Tumor Marker Testing * Cancer Diagnosis Market * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Global Cancer Diagnostics Market Growth Opportunities and StrategiesVPGMarketResearch.com is pleased to introduce a new seven-country, 1200-page report designed to help suppliers identify and evaluate emerging business opportunities in the global cancer diagnostics market.
"Future of Cancer Diagnostics Market: Growth Opportunities and Business Expansion Strategies" (http://www.vpgmarketresearch.com/ is a seven-country, 1200-page report designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the cancer diagnostics market during this decade. To review or order this report, visit http://www.vpgmarketresearch.com/ Contact Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com Highlights - Identifies and evaluates major business opportunities emerging in the cancer diagnostics market - Examines trends in the U.S., Europe and Japan - Reviews current and emerging cancer diagnostic tests - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major cancer diagnostic tests by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for suppliers. Geographic Coverage - France - Germany - Italy - Japan - Spain - UK - USA Market Segmentation Analysis - Sales and market shares of major suppliers, by individual test and country. - Ten-year test volume and sales forecasts for major cancer diagnostic tests by country and market segment, including: - Hospitals - Commercial/Private Laboratories - Physician Offices/Group Practices - Cancer Clinics - Ambulatory Care Centers - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. - Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries. Current and Emerging Products - Review of over 200 current and emerging cancer diagnostic tests, including: - Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and others. - Review of major analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices. Technology Review - Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. - Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy. - Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments - Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Worldwide Market Overview - Estimated universe of laboratories performing cancer diagnostic testing by country. - Ten-year test volume and sales projections by country. Business Opportunities and Strategic Recommendations - Specific new product development opportunities with potentially significant market appeal. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Methodology This report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U.S., five major European countries and Japan. The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPG's proprietary data files was conducted. Contains 1,200 pages and 450 tables Table of Contents Worldwide Market and Technology Overview A. Cancer Statistics and Etiology B. Major Current And Emerging Tumor Marker C. Instrumentation Review And D. Current and Emerging Technologies E. Competing/Complementing Technologies F. Business Environment G. Personal Testing France Germany Italy Japan Spain U.K. U.S.A. Major Product Development Opportunities A. Reagent Kits and Test Systems/Panels B. Instrumentation C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Factor Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Profiles - Abbott - AdnaGen - Ambrilia Biopharma - AMDL - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CanAG Diagnostics - CeMines - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - J&J Diagnostics - Kreatech - Kyowa Medex - Mackay Life Sciences - Matritech - Myriad Genetics - OncoLab - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac - Zila Contact Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com # # # Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. Specialties Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|